← Evidence map

ArticleJAMA2017

Zoledronic Acid Dosing Interval for Metastatic Cancer-Reply.

Andrew L Himelstein et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2017
2018
2019
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 28399247